Premium
Effects of a nurse‐led, clinic and home‐based intervention on recurrent hospital use in chronic heart failure
Author(s) -
Thompson David R.,
Roebuck Alun,
Stewart Simon
Publication year - 2005
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1016/j.ejheart.2004.10.008
Subject(s) - medicine , heart failure , confounding , randomization , clinical endpoint , hospital readmission , emergency medicine , randomized controlled trial
Background: Few studies have examined the potential benefits of specialist nurse‐led programs of care involving home and clinic‐based follow‐up to optimise the post‐discharge management of chronic heart failure (CHF). Objective: To determine the effectiveness of a hybrid program of clinic plus home‐based intervention (C+HBI) in reducing recurrent hospitalisation in CHF patients. Methods: CHF patients with evidence of left ventricular systolic dysfunction admitted to two hospitals in Northern England were assigned to a C+HBI lasting 6 months post‐discharge ( n =58) or to usual, post‐discharge care (UC: n =48) via a cluster randomization protocol. The co‐primary endpoints were death or unplanned readmission (event‐free survival) and rate of recurrent, all‐cause readmission within 6 months of hospital discharge. Results: During study follow‐up, more UC patients had an unplanned readmission for any cause (44% vs. 22%: P =0.019, OR 1.95 95% CI 1.10–3.48) whilst 7 (15%) versus 5 (9%) UC and C+HBI patients, respectively, died ( P =NS). Overall, 15 (26%) C+HBI versus 21 (44%) UC patients experienced a primary endpoint. C+HBI was associated with a non‐significant, 45% reduction in the risk of death or readmission when adjusting for potential confounders (RR 0.55, 95% CI 0.28–1.08: P =0.08). Overall, C+HBI patients accumulated significantly fewer unplanned readmissions (15 vs. 45: P <0.01) and days of recurrent hospital stay (108 vs. 459 days: P <0.01). C+HBI was also associated with greater uptake of beta‐blocker therapy (56% vs. 18%: P <0.001) and adherence to Na restrictions ( P <0.05) during 6‐month follow‐up. Conclusion: This is the first randomised study to specifically examine the impact of a hybrid, C+HBI program of care on hospital utilisation in patients with CHF. Its beneficial effects on recurrent readmission and event‐free survival are consistent with those applying either a home or clinic‐based approach.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom